Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

NLMK reported for 2023 by IFRS

4/16/24 NLMK

Rusal may lose about a third of its exports

4/16/24 RUAL

Kristall will produce Dominican rum

4/16/24 KLVZ

Rusolovo reported for 2023 by IFRS

4/15/24 ROLO

LSR sales in Q1 decreased by 8.7%

4/15/24 LSRG

Novoship reports for 2023 by IFRS

4/15/24 NOMP

Perm suspended the operation of kickshare services

4/15/24 WUSH

Ural Forge reported for 2023 by IFRS

4/15/24 URKZ

Board of Directors of Acron recommended dividends

4/15/24 AKRN

Lukoil opened the first gas station in Kazakhstan

4/15/24 LKOH